Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

<< Previous
Bullboard Posts
Next >>
Post by Sonny7on Jan 14, 2021 9:57pm
352 Views
Post# 32303579

Anticipation of News on Trial Results

Anticipation of News on Trial ResultsFrom the view of my clear lens glasses, streaked and somewhat oily, you don’t need to be a reservoir engineer to figure out that something good will flow out of this tomorrow and beyond. Let’s face it, this is a Doctor Witkowski show on the performance of the cell pouch and related actions with it in the scope of the FDA trials. After his peer reviewed paper, he will show us and some 600 surgeons the goods he is allowed. With his credibility as a fine surgeon and with a stellar reputation,....he must have some news of serious interest to many. We find out tomorrow. 

All things point to something very positive for many reasons. Along with that, it may show a bump in share price to the high side and the optimistic view would be to see share price find a new higher level from here. And that’s the bad news, possibly.?? On the strength of any upcoming news, the ultimate context of the news, after the fact, may just trigger thoughts to large pharma that they just can’t live without owning Sernova. Unless they know it already through confidentiality agreements, it should dangle a juicy bait or freshen up the bait in any case. 

exciting
<< Previous
Bullboard Posts
Next >>